Will the view from space be worth possible fertility complications? (Credit: Dima Zel on Shutterstock)
In A Nutshell
- Space radiation can damage reproductive DNA. A Mars trip exposes travelers to 662 millisieverts: levels known from medical research to threaten eggs and sperm.
- Commercial space companies have no binding safety standards for reproductive health, unlike NASA’s strict protocols for astronauts.
- Mouse embryos cultured in space show severe problems. Success rates dropped from 60% to 34%, with DNA damage and abnormal development.
- Fertility preservation technology exists but isn’t being offered. Automated systems and AI could protect space travelers, but no companies are implementing them.
Space tourism is officially here. Celebrities are posting selfies from orbit. Billionaires are planning luxury hotels on the Moon. Your neighbor might even be saving up for a trip to the edge of space. But, there’s one aspect of space travel that nobody’s talking about: the journey could quietly damage your ability to have children.
A major review in Reproductive BioMedicine Online has examined decades of research on how space affects human fertility, and the findings should worry anyone thinking about booking a ticket. Cosmic radiation can damage DNA in eggs and sperm. Weightlessness disrupts hormonal systems that regulate reproduction. Even the stress and disrupted sleep of space travel can derail reproductive function. And space tourists do not receive the years of medical screening and monitoring provided for NASA astronauts. There are no binding passenger safety standards that address reproductive risk, no required health warnings, no shared protocols about what companies must disclose.
The authors warn that commercial spaceflight is operating ahead of clear reproductive safety standards, with profit incentives potentially overriding medical caution.
The Radiation Problem Nobody’s Talking About
On Earth, the planet’s magnetic field shields us from the worst of space radiation. That protection vanishes once you leave the atmosphere. Astronauts on the International Space Station absorb about 0.5 millisieverts per day, far higher than typical daily exposure on Earth. On a round-trip to Mars, travelers would face approximately 662 millisieverts of cumulative radiation exposure: levels that fall within ranges known from medical research to threaten reproductive tissue.
Women face especially severe risks. Medical evidence from cancer radiotherapy shows that radiation doses as low as 2 grays can destroy half of a woman’s egg supply. The same biological vulnerability applies in space. Higher doses can trigger early menopause. Men aren’t immune either. While sperm may retain movement after space exposure, studies show DNA damage and impaired maturation that could affect future children. Doses above 250 milligray can cause permanent reductions in sperm count.
The Apollo astronauts who walked on the Moon spent only days in deep space, and their missions happened decades ago when they were young and healthy. Today’s space tourists might be older, on longer trips, with minimal medical screening. The risks multiply.
When Embryos Fail in Space
Scientists have tried growing mouse embryos aboard spacecraft, and the results are disturbing. In one Chinese experiment, embryos cultured in orbit for just 64 hours showed severe DNA damage and abnormal development. While most embryos successfully divided into early-stage cells, the rate at which they developed into blastocysts (the stage needed for pregnancy) dropped from about 60% on Earth to just 34% in space.
Japanese researchers found that freeze-dried sperm could survive extended stays on the space station and still produce healthy offspring, but that’s mice, not humans. And female eggs remain far more fragile and difficult to preserve.
Another experiment aboard the ISS examined whether key sperm maturation steps required for fertilization could proceed in microgravity. Critical processes were impaired, reducing the chances of successful conception. Space appears hostile not just to adult bodies, but to the earliest stages of human life.
The Commercial Space Oversight Gap
Here’s where things get ethically murky. NASA has strict protocols. Astronauts undergo extensive medical evaluations. Radiation exposure is carefully tracked. Career limits exist to prevent long-term damage. But space tourists? They’re paying customers on a commercial flight.
Companies like SpaceX and Blue Origin want to fill seats. Safety protocols are expensive. Medical screening might exclude wealthy clients. And right now, there are no shared, enforceable standards that clearly prohibit or manage these reproductive risks across the industry.
The regulatory vacuum is real. While launch and re-entry safety have oversight, passenger health protection during flight remains largely unaddressed. If your fertility gets damaged on a space vacation, you’re navigating uncharted legal and medical territory.
What Could Actually Help
Some solutions exist, at least in theory. Automation is revolutionizing fertility medicine on Earth. Robots can now perform delicate procedures like sperm injection, and early proof-of-concept births from automated systems have been reported. These technologies could theoretically work in space, preserving eggs or sperm before long missions.
AI can analyze sperm at the microscopic level, detecting DNA damage that human eyes would miss. Microfluidic “lab-on-a-chip” devices, already used on the space station for experiments, could enable fertility monitoring with minimal resources.
But right now, these are just possibilities. No commercial space company is offering pre-flight fertility preservation. No one’s monitoring reproductive health post-flight. The technology exists; the will to implement it doesn’t.
What Happens Next
The review’s authors are calling for an international framework to regulate reproduction in space. They want mandatory health disclosures for passengers, required fertility counseling before long missions, and a proposed pause on pregnancy and childbirth in space until safety can be proven through extensive research on Earth.
They’re also blunt about the stakes. Space travelers need to understand that the journey could affect not just them, but any children they might have afterward. Damaged DNA in eggs and sperm doesn’t always show up immediately. The consequences might emerge in the next generation.
The dream of becoming a multiplanetary species is compelling. But if the price is unknowingly risking human fertility and complicating future human reproduction beyond Earth, then the entire enterprise needs to pause and establish real safeguards.
For now, anyone considering space tourism should ask a question that marketing materials won’t answer: Is the experience worth the potential risk to your reproductive future? Because right now, nobody else is asking it for you.
Disclaimer: This article is based on a comprehensive scientific review published in a peer-reviewed medical journal and is intended for informational purposes only. It is not intended as medical advice. Individuals considering space travel should consult with qualified medical professionals regarding their specific health circumstances and any potential risks.
Paper Notes
Study Limitations
This review synthesizes existing research rather than presenting new experimental data. Most findings come from animal studies, particularly mice and rats, which may not perfectly mirror human reproductive biology. The limited number of human spaceflight missions with diverse crews means that sex-specific data remain sparse, especially for women on long-duration missions. Much of what is known about radiation effects comes from terrestrial medical contexts such as cancer radiotherapy and short-duration space missions, making long-term predictions for deep-space travel uncertain. The commercial space sector shares little medical data, further limiting comprehensive assessment.
Funding and Disclosures
Co-author Begum Aydogan Mathyk reports grant funding, patents, and advisory roles related to reproductive health in space research. She serves as Chair of NASA’s Open Science Data Repository Female Reproduction Analysis Working Group and is a partner in the SpaceMed programme at Charité Universitätsmedizin Berlin, Germany. No funding from these projects was used in the preparation of this review. The remaining authors engage in space research activities, but these activities are independent of the present review, and no external funding or institutional support related to them was used in its preparation.
Publication Details
Authors: Giles Anthony Palmer (International IVF Initiative Inc., IVF 2.0 Ltd., Institute of Life IASO Greece, Vitalab South Africa), Begum Aydogan Mathyk (University of South Florida, Yale University), Jeffrey Jones (Baylor College of Medicine), Blair T. Stocks (Baylor College of Medicine), Paul Root Wolpe (Emory University, SolaMed Solutions LLC), Virginia Wotring (International Space University), Christopher E. Mason (Weill Cornell Medicine), Jacques Cohen (Conceivable Life Sciences, Althea Science), Fathi Karouia (Blue Marble Institute of Science, Space Research Within Reach, BioServe Space Technologies University of Colorado Boulder, Baylor College of Medicine) | Journal: Reproductive BioMedicine Online | Title: “Reproductive biomedicine in space: implications for gametogenesis, fertility and ethical considerations in the era of commercial spaceflight” | DOI: https://doi.org/10.1016/j.rbmo.2025.105431 | Citation: Palmer GA, Mathyk BA, Jones J, Stocks BT, Wolpe PR, Wotring V, Mason CE, Cohen J, Karouia F. Reproductive biomedicine in space: implications for gametogenesis, fertility and ethical considerations in the era of commercial spaceflight. Reprod Biomed Online. 2025;105431.







